In a previous report we proposed a role for SSX in EMT based on our findings that in a melanoma cell line and in fetal mesenchymal stem cells, the expression of SSX was associated with a mesenchymal phenotype such as increased cell invasion capacity, decreased E-cadherin and increased matrix proteinase 2 (MMP2) expression [5]. The gene discussed is SSX2; the disease is melanoma.